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HDreatment-Resistant Depression
nd Sudden Cardiac Death
hang et al. (1) recently reported some very interesting data from
he Nurses’ Health Study showing that depression predicts
ardiac-related mortality and that a proxy indicator of clinical
epression (either scoring in the depressed range on the Mental
ealth Index-5 using antidepressant medication) predicted sudden
ardiac death in a large cohort of female nurses. The authors are to
e commended for their outstanding work. The key question is
ow to interpret their findings.
Recent clinical trials in patients after acute coronary syndrome
uggest that depression that does not respond to standard treat-
ents is associated with a particularly high risk of cardiac mor-
idity and mortality (2). Thus, it is not being on an antidepressant
er se that increases risk, but rather being on an antidepressant and
emaining depressed. Treatment-resistant depression might also
onfer a higher risk of sudden cardiac death in individuals without
nitial clinical evidence of heart disease.
Possible support for this conclusion is evident in Figure 3 of the
aper by Whang et al. (1). It shows 4 Kaplan-Meier curves of time
o sudden cardiac death, defined by combinations of the presence
r absence of clinical depression and whether or not the individual
as taking an antidepressant. One group, those who remained
epressed despite taking an antidepressant, seems to be at much
igher risk for sudden cardiac death than the other 3 groups.
We encourage the authors to compare the nondepressed/no
ntidepressant reference group with each of the other 3 groups. If
he patients on antidepressants who remain clinically depressed are
t the highest risk of sudden cardiac death, the results would
upport our interpretation. This would be strengthened if it could
e established that these individuals had received a therapeutic
ose of the antidepressant agent for sufficient duration to classify
hem as treatment nonresponders.
Regardless, depression that does not respond to treatment is
ssociated with cardiac morbidity and mortality in post-acute
oronary syndrome patients and may be the most plausible
xplanation for the findings by Whang et al. (1). It is not known
hy treatment-resistant depression confers a high risk for cardiac-
elated mortality or sudden cardiac death. A variety of factors that
ave been associated with treatment resistance are also risk factors
or cardiac events, including elevated inflammatory markers,
ypothalamic-pituitary-adrenal axis dysregulation, and low thyroid
ormone levels (2). However, further research is needed to
efinitively explain this relationship.
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eply
e thank Drs. Carney and Freedland for their perspective on our
tudy (1). We performed the analyses that they suggested by
stimating separate hazard ratios for 4 categories of women from
he Nurses’ Health Study according to presence of severe depres-
ive symptoms (Mental Health Index-5 score 53) and/or re-
orted use of antidepressant medications. In multivariable analy-
es, the hazard ratios associated with each category are listed in
able 1. The risk of sudden cardiac death was significantly elevated
mong women treated with antidepressants regardless of whether they
ontinued to show severe depressive symptoms. Although the hazard
atio was slightly higher among those who showed severe depressive
ymptoms, confidence intervals overlapped. Also, we did not find
vidence for an interaction between the Mental Health Index 5 score
ategory and antidepressant use in separate multivariable models that
sed a cross-product term. Therefore, we were unable to find strong
vidence in support of the hypothesis of Drs. Carney and Freedland
n our data; however, we strongly agree that further research into the
rognosis of depression and treatment-resistant depression, and the
nderlying mechanisms, is needed.
azard Ratios for Sudden Cardiaceath Associated With Each C tegory
Table 1
Hazard Ratios for Sudden Cardiac
Death Associated With Each Category
Category
Hazard Ratio
(95% Confidence
Interval) p Value
MHI-5 score 53, no antidepressant Referent
MHI-5 score 53, no antidepressant 0.76 (0.24–2.43) 0.64
MHI-5 score 53, antidepressant use 3.11 (1.80–5.36) 0.001
MHI-5 score 53, antidepressant use 3.99 (1.69–9.42) 0.002HI-5  Mental Health Index-5.
